Introduction
============

Epidemiological studies have shown associations between fine particles (PM~2.5~) and health outcomes such as hospital admissions and mortality ([@r5]; [@r11], [@r12]; [@r27]), but these studies are primarily based in urban areas owing to the placement of ambient monitors that provide the necessary exposure data. Consequently, the majority of PM~2.5~ health effects estimates are derived from urban populations. Although toxicological and individual- and population-level studies provide strong evidence that PM~2.5~ adversely affects health, key questions remain.

Current evidence on short-term PM~2.5~ exposure and health has critical limitations. First, estimates from many multi-city studies are obtained by pooling estimates from counties with monitoring data, thereby completely disregarding health effects in communities without monitoring data, which tend to be more rural ([@r10]). This lack of monitoring data outside of urban areas precludes estimation of exposure and health effects in such locations, and as a result, it is unknown whether and to what extent health effects in monitored versus unmonitored, or urban versus rural, communities differ. Recently, researchers have used satellite data to estimate PM~2.5~ exposures ([@r26]; [@r29]) and health outcomes in areas without monitoring data ([@r23]; [@r27]).

A second limitation is that by relying exclusively on monitoring data primarily from urban counties, studies cannot fully investigate susceptibility. Populations in urban counties differ demographically from those in nonurban (more rural) counties ([@r32]) and may have dissimilar exposure levels or health responses to exposure. Regional and temporal differences have been observed in PM~2.5~ composition and health effect estimates ([@r4]); PM~2.5~ composition and time trends likely differ by urbanicity. Populations' baseline health status and comorbidities (e.g., obesity), demographic and behavioral risk factors (e.g., tobacco use), and other factors differ between urban and nonurban communities. For example, rural communities have greater barriers to health care access ([@r46]), higher rates of many chronic diseases ([@r14]; [@r20]), and different activity patterns ([@r31]) than urban communities. Thus, PM~2.5~ exposures and susceptibility may differ between urban and nonurban populations, but such differences are not captured in currently available health effect estimates.

Third, most PM~2.5~ monitors sample every 3 days, prohibiting study of short-term cumulative exposures. Health effects of PM~2.5~ may depend on both the concentration and the duration of exposure. Same- or single-day lags of PM~2.5~ exposure may not fully capture health risk if the risk is affected by exposure experienced over multiple days, as some studies have suggested ([@r49]).

Previous time-series PM~2.5~ studies, which are subject to the abovementioned limitations, studied up to 204 urban counties in the United States ([@r5]; [@r12]). We utilized output from the Community Multi-scale Air Quality (CMAQ) model downscaler to estimate daily PM~2.5~ levels in monitored and nonmonitored areas for \> 700 U.S. counties for 2002--2006. With daily downscaler-derived estimates of PM~2.5~, we estimated county-specific and overall health effects associated with short-term exposure to PM~2.5~ in populations excluded from previous studies. We also examined the health impacts of short-term cumulative exposures, which is only possible with daily PM~2.5~ estimates.

Methods
=======

Health Data
-----------

We used files from the Centers for Medicare and Medicaid Services (CMS) to identify beneficiaries ≥ 65 years old who were enrolled in the Fee-for-Service plan for ≥ 1 month from 1 January 2002 to 31 December 2006. Using beneficiaries' residential ZIP codes, we identified those who resided in 1 of the study area's 795 U.S. counties with a population ≥ 50,000 in the 2000 U.S. Census ([@r43]).

We linked this data set with CMS inpatient data to identify beneficiaries hospitalized with a principal discharge diagnosis of cardiovascular \[*International Classification of Diseases, Ninth Revision, Clinical Modification* (ICD-9-CM) 390 to 459\] or respiratory conditions (chronic obstructive pulmonary disease) (ICD-9-CM 490 to 492) or respiratory tract infections (ICD-9-CM 464 to 466, 480 to 487), from 1 January 2002 to 31 December 2006. Using dates of admission, we constructed our final sample of daily cardiovascular or respiratory hospital admission rates, aggregated at the county level (the data set identifying beneficiaries ≥ 65 years by county was used as the denominator in county-specific rate calculations). Of the 28,019,815 unique beneficiaries, 4,860,662 (17.3%) and 1,855,699 (6.62%) had at least one cardiovascular- or respiratory-related hospital admission, respectively, during the study period.

Exposure Data
-------------

Daily (24 hr) averages of PM~2.5~ monitoring data (2002--2006) were obtained from the U.S. Environmental Protection Agency (EPA) National Air Monitoring Stations or State and Local Air Monitoring Stations (NAMS/SLAMS) network. Downscaler output was obtained for 2002--2006 (<http://www.epa.gov/air-research/fused-air-quality-surfaces-using-downscaling-tool-predicting-daily-air-pollution>). Inputs to the downscaler include monitoring data from the NAMS/SLAMS network and CMAQ numerical output, specifically, 24-hr PM~2.5~ concentrations at 12 km × 12 km grid cells simulated using CMAQ version 4.6 ([@r21]). CMAQ is a sophisticated and extensively reviewed ([@r1]; [@r2], [@r3]) regional air quality model that estimates pollutant concentrations and deposition fluxes at local, regional, and continental scales. Using meteorological and emissions data, CMAQ simulates pollutant transformation, transport, and fate. Meteorological variables were estimated using 5th generation Penn State/NCAR Mesoscale Model version 3.6.3. The emissions inventory was based on the 2002 National Emissions Inventory and daily continuous emissions monitoring data for major point sources of nitrogen oxides ([@r21]).

The downscaler uses monitoring data and gridded CMAQ output (12 km × 12 km) to estimate daily air pollution concentrations at census tract centroids using linear regression modeling with additive and multiplicative bias coefficients that can vary spatially and temporally ([@r7], [@r8], [@r9]). Downscaler estimates are used in the U.S. EPA's Environmental Justice mapping and screening tool (EJSCREEN) ([@r45]) and studies of air pollution and health ([@r18]). Although the downscaler was developed to provide predictive surfaces of air pollution for health studies relating daily pollution levels to daily health outcomes ([@r21]), downscaler performance in locations without monitoring data, which correspond primarily to less-urban areas, is not well characterized. Thus, use of downscaler output allows us to estimate exposures and health effects in nonurban locations, but the resulting health effect estimates should be interpreted with care because there may be significant differences in downscaler performance in urban versus less-urban locations.

We used downscaler output consisting of daily PM~2.5~ concentration estimates at census tracts for the eastern two-thirds of the United States, the region for which downscaler output are available for 2002--2006 ([Figure 1](#f1){ref-type="fig"}). Further details on the downscaler methodology, results, and validation are available elsewhere ([@r9]).

![Percent of county population residing in urban areas. Urban populations reside in census blocks with (1) population density of ≥ 1,000 people/mi^2^ (386.1 people/km^2^) and (2) surrounding blocks with a density of ≥ 500 people/mi^2^ (193.1 people/km^2^). Rural populations are any population located outside of urban census blocks ([@r44]). Shading indicates which counties were included in the study (*n *= 708 counties), with dark gray representing the most-urban counties and light gray representing the most-rural counties. Counties with the highest levels of urbanicity (\> 90% of county population residing in urban settings) primarily correspond to counties containing or surrounding the following major cities: Houston, San Antonio, Austin, Odessa, Laredo, Brownsville, Corpus Christi, El Paso, and Dallas/Fort Worth, TX; Albuquerque, NM; Denver, Aurora, and Colorado Springs, CO; Omaha and Lincoln, NE; Tulsa and Oklahoma City, OK; Wichita and Kansas City, KS; Minneapolis--St. Paul, MN; Milwaukee, WI; Chicago, IL; St. Louis, MO; Fort Wayne and Indianapolis, IN; Detroit, MI; Buffalo and Schenectady, NY; Pittsburgh, PA; Nashville and Memphis, TN; Louisville and Lexington, KY; Cincinnati, Cleveland, Columbus, and Toledo, OH; Washington, DC; Norfolk, VA; Charlotte, Greensboro, and Raleigh, NC; Atlanta, GA; New Orleans and Baton Rouge, LA; and Tampa, Orlando, Miami, and Jacksonville, FL. There is a corridor of high-urbanicity counties along the eastern seaboard, extending roughly from Baltimore, MD to Boston, MA. The most-urban counties are often bordered, at least in part, by other counties with moderate to high levels of urbanicity (e.g., 41--90% of county population residing in urban settings). More-rural counties are more common in interior (i.e., non-coastal) areas of the southeast, including Oklahoma, the Northeast, the Ohio River Valley, and the Midwest. Ambient PM~2.5~ monitors are more likely to be sited in areas with higher levels of urbanicity. County boundaries are drawn according to Census 2000 Topologically Integrated Geographic Encoding and Referencing (TIGER)/Line files (https://www.census.gov/geo/maps-data/data/tiger-line.html). PM~2.5~, fine particulate matter.](EHP257.g001){#f1}

We generated 24-hr county-level PM~2.5~ estimates using multiple approaches. We only estimated exposures for counties with populations ≥ 50,000 (*n* = 795) to ensure sufficient sample size. First, we used the standard approach of estimating exposures from monitoring data for counties with monitors (*n* = 446) and days with observations. Approximately 80% of PM~2.5~ monitors record observations once every 3 days. Multiple monitor measurements for the same day and county were averaged. Second, county-level 24-hr PM~2.5~ exposures were calculated from a population-weighted average of PM~2.5~ concentrations predicted by the downscaler at census tracts within each county using 2000 U.S. Census data ([@r43]). These exposure estimates, hereafter referred to as "CMAQds," were generated for 795 counties in the study area with a population ≥ 50,000 and all days in the study period (2002--2006). Lastly, we subset the CMAQds data set and calculated population-weighted county-level exposures *only* for counties and days with monitoring data. The data set of county-level PM~2.5~ exposures derived from downscaler output but restricted to days and counties with monitoring data is referred to as the "CMAQds_subset."

Thus, we have three data sets of county-level exposure estimates derived from *a*) PM~2.5~ monitoring data, *b*) all available downscaler output (CMAQds), and *c*) downscaler output only in counties and on days with monitoring data (CMAQds_subset). The attributes of each PM~2.5~ data set and the methods used to estimate exposures are summarized in Table S1. We used metrics from the literature ([@r51]) to assess whether monitor- and downscaler-derived exposure estimates were similar.

Counties were divided into five urbanicity categories based on percent of the county population residing in urban settings. According to the census, urban populations reside in census blocks with *a*) population density ≥ 1,000 people/mi^2^ (386.1 people/km^2^) and *b*) surrounding census blocks with population density ≥ 500 people/mi^2^ (193.1 people/km^2^); rural populations reside in blocks that do not meet these criteria ([@r44]). Urban/rural categories are mutually exclusive, that is to say, 100 minus the percentage of the population residing in urban areas equals the percentage of the population residing in rural areas. The five categories of urbanicity consisted of counties with \> 90%, 81--90%, 61--80%, 41--60%, and ≤ 40% of the population residing in urban settings. The percentage of the population in urban and rural (referred to here as "nonurban") settings was obtained from the 2000 Census Summary File 3 ([@r43]).

Daily temperature and dew point temperature data were obtained from the [@r33]. Daily 24-hr estimates of temperature and dew point temperature for each county were generated from observations from all weather stations within the county. If a county did not have a weather monitor, weather data from the closest county within 30 mi (48.3 km) were used. Counties with insufficient meteorological data (*n* = 87) were removed from the analysis. This restriction resulted in 418 counties in the monitor and CMAQds_subset exposure data sets and 708 counties in the CMAQds exposure data set.

Statistical Analysis
--------------------

Health effects were estimated using two-stage Bayesian hierarchical modeling, an approach described elsewhere ([@r6]). In the first stage, log-linear Poisson regression models with over-dispersion were fit to county-specific time-series data on hospital admission rates and PM~2.5~ concentrations, adjusted for covariates. We chose covariates based on previous analyses ([@r12]). Covariates included smooth functions (natural cubic spline) of same-day (day 0) temperature and dew point temperature \[degrees of freedom (df) = 6\], 3-day moving average of temperature and dew point temperature for days 1--3 (df = 3), and time to account for long-term trends in hospitalizations (df = 8/year), as well as categorical variables for age (65--74 years old, \> 74 years old) and day of the week. The age variable was included to account for differential effects of air pollution by age, as has been done in previous studies ([@r5]). Lags for temperature and dew point temperature were consistent across all analyses.

In the second stage, we estimated the short-term association between PM~2.5~ and hospital admissions for the entire study area using two-level normal independent sampling estimation with noninformative priors ([@r16]). This technique allowed us to combine relative risk estimates across counties while accounting for within-county statistical error and between-county variability in the true relative risks. The result was an overall effect estimate of the relationship between PM~2.5~ and hospital admissions across all counties. Alternatively, we could estimate the relationship between PM~2.5~ and hospitalizations for selected groups of counties that share characteristic(s) of interest, such as degree of urbanicity. Each hospitalization type (cardiovascular or respiratory) and PM~2.5~ data set (CMAQds, CMAQds_subset, or monitor-based estimates) was analyzed separately. County-level and overall (combined) effects were estimated for cardiovascular outcomes and respiratory outcomes at lag 0, lag 1 (previous day exposure), and lag 2. Effect estimates were compared to determine if they were significantly different based on the method of [@r40].

To investigate whether PM~2.5~-hospitalization associations differed for single or multiple days of exposure, we fitted a distributed lag model with multiple lags of pollution (0- to 7-day lags) simultaneously included in the county-specific model. We then investigated whether effect estimates differed for more- versus less-urban counties using CMAQds-derived exposures, performing analyses stratified by the five urbanicity categories discussed previously.

The results are presented as the estimated percent increase in hospital admissions associated with a 10-μg/m^3^ increase in PM~2.5~ across a specified number of days. Statistical significance was assessed by the 95% posterior intervals (PI) excluding the value of zero. Statistical analyses were performed using R (version 3.2.1; R Project for Statistical Computing) and using the tlnise package for two-level normal independent sampling.

Results
=======

Observed concentrations are compared with CMAQds predictions in Table S2; see Figure S1 for a map of monitoring data availability by county. The mean daily county-level concentrations derived from the monitoring data and CMAQds_subset were 12.48 μg/m^3^ and 12.60 μg/m^3^, respectively. The mean and median within-county correlation between monitored and CMAQds_subset-predicted county-level concentrations were 0.96 and 0.97, respectively (standard deviation = 0.032; minimum and maximum = 0.72 and 0.99, respectively) (see Figure S2). The average normalized mean bias was \< 1%, indicating that systematic bias in CMAQds_subset-predicted county-level PM~2.5~ concentrations was low.

PM~2.5~-hospitalization associations were estimated using exposures derived from *a*) monitoring data (*n* = 418 counties), *b*) CMAQds_subset (*n* = 418 counties), and *c*) CMAQds (*n* = 708 counties). County-specific maximum likelihood effect estimates resulting from the first-stage model using monitor- and CMAQds-derived exposure estimates are summarized in Figure S3. Overall estimates of cardiovascular and respiratory associations using different exposure data sets were similar ([Table 1](#t1){ref-type="table"}): based on CMAQds-derived exposure estimates, a 10-μg/m^3^ increase in PM~2.5~ was associated with a 1.16% (95% PI: 0.88%, 1.45%) increase in same-day (lag 0) respiratory admissions and a 0.79% (95% PI: 0.62%, 0.97%) increase in same-day cardiovascular admissions. Using CMAQds-derived exposure estimates, positive, statistically significant associations were observed for cardiovascular hospitalizations at lag 0 and for respiratory hospitalizations at lag 0, lag 1, and lag 2 ([Table 1](#t1){ref-type="table"}). Effect estimates from the different exposure data sets at the single lags examined (lag 0, 1, and 2) were similar in magnitude and were not significantly different from one another. For respiratory hospitalizations, lag 0 effect estimates tended to be larger than lag 1 or lag 2 effects regardless of the exposure estimates used. Cardiovascular effect estimates at lag 2 were negative when CMAQds_subset exposures were used \[--0.20% (95% PI: --0.43%, --0.03%)\].

###### 

Percent increase in hospital admissions associated with a 10 μg/m^3^ increase in PM~2.5~ concentration, 2002--2006.

  Health effect                                                                                                                                              Monitor data (*n*= 418 counties) Estimate (95% PI)   CMAQds_subset (*n*= 418 counties) Estimate (95% PI)   CMAQds (*n*= 708 counties) Estimate (95% PI)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------- ----------------------------------------------------- ----------------------------------------------
  Cardiovascular                                                                                                                                                                                                                                                        
  Lag 0                                                                                                                                                      0.87 (0.65, 1.09)\*                                  0.98 (0.73, 1.23)\*                                   0.79 (0.62, 0.97)\*
  Lag 1                                                                                                                                                      0.15 (--0.06, 0.37)                                  0.15 (--0.09, 0.38)                                   --0.004 (--0.16, 0.15)
  Lag 2                                                                                                                                                      --0.14 (--0.36, 0.07)                                --0.20 (--0.43, --0.03)\*                             0.09 (--0.06, 0.24)
  Respiratory                                                                                                                                                                                                                                                           
  Lag 0                                                                                                                                                      1.10 (0.70, 1.50)\*                                  1.11 (0.66, 1.56)\*                                   1.16 (0.88, 1.45)\*
  Lag 1                                                                                                                                                      0.37 (0.01, 0.78)\*                                  0.38 (--0.02, 0.80)                                   0.29 (0.015, 0.58)\*
  Lag 2                                                                                                                                                      0.57 (0.22, 0.93)\*                                  0.57 (0.18, 0.96)\*                                   0.37 (0.11, 0.63)\*
  Notes: CMAQds, Community Multi-Scale Air Quality downscaler exposure estimates; PI, posterior interval; PM~2.5~, fine particulate matter. \**p* \< 0.05.                                                                                                              

Daily CMAQds-derived exposure estimates allowed investigation of short-term cumulative lag effects. We used daily CMAQds-derived exposure estimates to include multiple single-day lags of PM~2.5~ concentration simultaneously in a distributed lag model, allowing pollution over multiple previous days to influence health ([@r37]). Health effects estimated for up to 7 days of multi-day lags (lag 01--07) using CMAQds-derived exposure estimates are presented in [Figure 2](#f2){ref-type="fig"}. Point estimates for cardiovascular admissions decreased as more days were included in the lag structure but remained similar (range: 0.65--0.89% increase in admissions per 10 μg/m^3^ PM~2.5~ increase). Associations for respiratory hospitalizations were positive and statistically significant from lag 01 to lag 06, and effect estimates increased with additional days included in the lag through lag 07. The largest association was observed for lag 01 \[0.89% (95% PI: 0.51%, 1.28%)\] for cardiovascular admissions and lag 06 \[2.47% (95% PI: 0.29%, 4.69%)\] for respiratory admissions. Sensitivity analyses indicated that larger PM~2.5~ effects for respiratory outcomes at longer lag times were not attributed to uncontrolled temperature effects at longer lags. Lag results should be interpreted with caution: CMAQds-derived estimates may have greater day-to-day correlation than monitoring data because emissions inputs to CMAQ are correlated across time.

![Percent increase in hospital admissions associated with a 10 μg/m^3^ increase in fine particulate matter (PM~2.5~) concentration, estimated for short-term distributed lags, using Community Multi-scale Air Quality (CMAQds) exposure estimates. Vertical lines represent 95% posterior intervals.](EHP257.g002){#f2}

For the urbanicity analysis, we divided counties into five groups based on the percentage of county population residing in urban areas. Of 708 counties, 153 had \> 90% of the population residing in urban settings (median population density = 477 people/km^2^), 113 counties had 81--90% of the population in urban areas (139 people/km^2^), 235 counties had 61--80% of the population in urban areas (78 people/km^2^), 140 counties had 41--60% of the population in urban areas (50 people/km^2^), and 67 counties had ≤ 40% of the population in urban areas (34 people/km^2^) ([Figure 1](#f1){ref-type="fig"}). Mean PM~2.5~ for each of the urbanicity groups was not significantly different (Student's *t*-test with Welch correction for unequal variances). Counties with \> 90% or 61--80% of the population residing in urban areas had the highest average PM~2.5~ concentrations (12.5 μg/m^3^), and counties with ≤ 40% of the population residing in urban areas had the lowest concentration (11.8 μg/m^3^). The standard error of PM~2.5~ concentrations associated with downscaler predictions did not differ substantially by urbanicity (results not shown). Average (minimum--maximum) counts of daily county-level cardiovascular-related hospitalizations ranged from 1.88 (0--15) in the most nonurban counties to 13.8 (0--224) in the most urban counties. For respiratory hospitalizations, average (minimum--maximum) counts of daily county-level hospitalizations ranged from 0.73 (0--10) in the most nonurban counties to 4.44 (0--153) in the most urban counties.

[Figure 3](#f3){ref-type="fig"} shows health effect estimates by urbanicity category (lag 0), estimated using CMAQds exposure estimates. Cardiovascular effect estimates increased with increasing urbanicity. In contrast, the largest effect for respiratory hospitalizations \[2.57% (95% PI: 0.87%, 4.30%) for a 10-μg/m^3^ increase in lag 0 PM~2.5~\], was observed in counties with ≤ 40% of the population in urban areas. We also observed positive, statistically significant respiratory associations in some of the more-urban populations. Our findings indicate that cardiovascular effects were higher in the most-urban counties, whereas respiratory effects were highest in the least-urban counties. However, respiratory and cardiovascular effect estimates for counties with differing levels of urbanicity were not significantly different. We considered alternative groupings of urbanicity and found that categorizing urbanicity using four or five levels gave very similar results (results not shown). Health effect estimates by urbanicity estimated only for counties with monitoring data are provided in Figure S4.

![Percent increase in hospital admissions associated with a 10 μg/m^3^ increase in fine particulate matter (PM~2.5~) concentration, estimated for counties with different levels of urbanicity (lag 0). Vertical lines represent 95% posterior intervals.](EHP257.g003){#f3}

Discussion
==========

Our principal findings include the following: *a*) evidence that PM~2.5~ may exert higher cardiovascular risk in urban populations; *b*) suggestive evidence that PM~2.5~ is more detrimental to respiratory health in nonurban populations; and *c*) evidence that respiratory health, more so than cardiovascular health, is affected by PM~2.5~ over the past few days. Our findings with respect to urban populations are consistent with those of previous studies focusing primarily on urban populations, which observed associations between short-term PM~2.5~ exposure and cardiorespiratory health (e.g., [@r12]; [@r28]; [@r39]; [@r47]). However, our findings also indicate that estimating risks using monitor data alone may underestimate the true effect across urban and nonurban populations, which occurs at a lag of a week (or longer) for respiratory hospitalizations.

Scientific evidence on urban and nonurban differences in PM~2.5~ composition is extremely limited ([@r24]), in part because of the dearth of monitors in less-urban areas. An analysis of hospitalizations and satellite-derived PM~2.5~ estimates in the mid-Atlantic United States found differences in associations between PM~2.5~ and cardiovascular hospitalizations in urban and rural populations ([@r27]); others observed associations between respiratory health and urbanization ([@r15]). The urban--nonurban discrepancies in health response that we observed could have resulted from multiple factors, such as differences in exposure to pollutant mixtures (e.g., source-dependent PM~2.5~ composition), susceptibility to a given exposure in each population (e.g., baseline health status, access to or quality of health care, coexposures, comorbidities), and exposure measurement error.

Increasingly, evidence indicates that PM toxicity relates to chemical composition ([@r28]; [@r30]) and source ([@r24]). PM~2.5~ chemical composition varies by geography, source, and season ([@r4]). Pollutant mixtures, and their associated toxicity, may differ by urbanicity ([@r41]), which could affect observed associations. These variations could explain our findings that urban/nonurban differences in associations vary by cause of hospital admission because different chemical structures may affect health through different physiological pathways.

Urban and nonurban populations may have differential susceptibility to a given level of air pollution exposure ("effect modification") ([@r19]), which could relate to health care, lifestyle, activity patterns, and comorbidities or risk factors. Compared with urban areas, nonurban areas have higher poverty levels ([@r22]), fewer physicians per capita, and greater transportation barriers to health care ([@r13]; [@r46]). Distributions of comorbidities or risk factors in urban and nonurban populations may play a role in susceptibility to PM~2.5~. For example, a study of diabetes and coronary heart disease indicated that disease prevalence rates were higher in nonurban areas, but after adjusting for risk factors (e.g., poverty, obesity, tobacco use), prevalence was lower among respondents in nonurban areas than those in urban areas ([@r34]). Lifestyle factors and activity patterns may also play a role: compared with nonurban residents, urban residents are more likely to engage in physical activity ([@r36]). Research in Canada found that rural populations spent significantly more time working outdoors ([@r31]). Such differences may affect not only susceptibility but also exposure levels.

Exposure measurement error may also contribute to differences in effect estimates for urban and nonurban counties. One key challenge is that evaluation of exposure estimates through comparison to monitoring data is limited in nonurban areas because of the lack of monitors. Validation of downscaler PM~2.5~ concentrations is only possible in locations with monitoring data; thus, it is not possible to evaluate downscaler performance in counties without ambient monitors, which tend to be less urban. However, less-urban areas are the very locations where exposure estimates are most needed. [@r50] identified three components of measurement error: *a*) difference between individual exposures and average personal exposure, *b*) difference between average personal exposure and ambient levels, and *c*) difference between measured and true ambient concentrations. The difference between downscaler-predicted and measured ambient concentrations is particularly relevant to our study. The downscaler incorporates information from ambient monitors, which are generally located in more urban settings, such that exposure estimates may have less measurement error in more-urban areas. One study of exposure measurement error in a time-series context such as ours indicated that larger differences between measured and true concentrations resulted in attenuated estimates of health risk ([@r17]). However, depending on the error type (e.g., classical, Berkson), risk ratios could be attenuated or biased away from the null. Other issues (e.g., chemical composition, comorbidities) may be as important as or more important than measurement error.

Another principal finding is the lag structures observed for PM~2.5~ exposure and impacts on respiratory and cardiovascular hospitalizations. We found that the largest impact of PM~2.5~ on cardiovascular hospitalizations occurred at short lag time of 0--1 days, whereas the largest impact on respiratory hospitalizations occurred at a lag of a week ([Figure 2](#f2){ref-type="fig"}). This finding is consistent with those of a previous study of particulare matter with an aerodynamic diameter ≤ 10 μm (PM~10~) ([@r49]), in which the risk of respiratory mortality increased five-fold when PM~10~ exposure was characterized by longer distributed lags. Our findings with respect to lags are also consistent with those of several city-specific investigations that used daily air pollution data to evaluate lags between PM~2.5~ and cardiovascular- and respiratory-related morbidity and mortality, including studies in Denver, Colorado; Seattle, Washington ([@r25]); and Detroit, Michigan ([@r52]), among others ([@r42]). This is a critical point because it is not possible to estimate the health impacts of short-term cumulative exposures in most U.S. locations using traditional methods given that very few monitors measure PM~2.5~ daily. Of 708 counties in the present analysis, only 57 (8.1%) had \> 90% of days with monitoring data. As a result, any analysis of cumulative exposures using monitoring data is necessarily constrained to areas with daily monitoring data, which are overwhelmingly urban.

Moreover, our analysis indicated that counties for which short-term cumulative exposure and health effects could be estimated using monitor-derived exposures (i.e., primarily urban counties with daily data), had lower effect estimates for respiratory hospitalizations than other counties (i.e., those with less PM~2.5~ monitoring data availability) (results not shown). Thus, respiratory health effects modeled using distributed lag exposures obtained from counties with near-complete monitoring data may not be generalizable to counties with few or no monitoring data and may in fact underestimate health effects in such counties.

Our study has several limitations. Our analysis was restricted to counties with populations ≥ 50,000 in the 2000 U.S. Census, which limits how nonurban included counties can be because more sparsely populated rural counties often have populations \< 50,000. This analytical design was chosen for sample size considerations, and our findings indicate that further investigation of health impacts of air pollution in nonurban populations is warranted. Although we evaluated CMAQds performance with respect to monitoring data, CMAQds performance cannot be evaluated in areas with limited or no monitoring data. Differences between CMAQds-derived exposure estimates and monitor-derived exposure estimates may be greater in less-urban counties because there are few or no monitoring data to use as input to the downscaler in less-urban areas. Clearly, there is less opportunity to validate CMAQds-derived exposure estimates in places without monitors, the very places where exposure estimates are most needed. The potential difference in error between urban and less-urban counties means that differences in risk estimates for urban and less-urban counties must be interpreted with caution, and this is an area in which the need for further research is acute. We do not have substantial data on spatial variability or urban/nonurban differences in PM~2.5~ composition or copollutant concentrations or mixtures. Additionally, although the ≥ 65 years of age demographic is one of the fastest-growing segments of the U.S. population ([@r35]), and older individuals may have heightened susceptibility to air pollution ([@r38]), health effects estimated for elderly individuals are not necessarily generalizable to the U.S. population or to other potentially susceptible populations. This study was limited to areas were CMAQds-predicted concentrations were available for 2002--2006.

Strengths of this study include the investigation of several important questions that were not addressed in previous studies: for example, health effect estimates in nonurban counties were not addressed because monitors tend to be sited in urban locations; furthermore, health effects of short-term cumulative exposures (distributed lags) were not investigated. A major strength of this study is inclusion of understudied populations residing in nonurban areas: previous multi-city studies of air pollution have been based exclusively in more-urban counties and communities, and city-specific studies also tend to focus on metropolitan areas ([@r48]). Another significant strength is our analysis of short-term distributed lags in areas with nondaily monitoring data or with no data. Future work could incorporate uncertainty associated with downscaler predictions into the exposure and health effect estimates; investigate whether results are affected by comorbidities, lifestyle, or risk factors that may affect susceptibility to air pollution or cardiovascular or respiratory disease; and examine even more rural counties by pooling populations in adjacent counties or by similar methods.

Conclusion
==========

As a result of urban bias in epidemiological studies, which is largely driven by data availability, the health impacts of air pollution in nonurban locations are largely unknown. Health effect estimates for predominantly urban populations may not be generalizable to nonurban areas, where \> 59 million people live in the United States. Further, estimating health effects of PM~2.5~ with nondaily data may underestimate true health effects, particularly for respiratory-related hospitalizations. Health analyses in urban locations, with large populations and high pollution levels, are useful from public health impact and regulatory perspectives; however, health outcomes for large numbers of people remain poorly understood. Our findings indicate significant respiratory health impacts in nonurban areas and over a multiday exposure period. Additional research is needed to investigate the health impacts of air pollution on nonurban populations and to explore the differences in health effect estimates presented here.

**Editor's Note:** In the Advance Publication, the images were reversed between [Figures 2](#f2){ref-type="fig"} and [3](#f3){ref-type="fig"}. The images and captions are now in the correct positions.
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